Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide

The contribution of the bone marrow microenvironment in myelodysplastic syndrome is controversial. We therefore analyzed the functional properties of primary mesenchymal stromal cells from patients with myelodysplastic syndrome in the presence or absence of lenalidomide. Compared to healthy controls...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ferrer, Ruben A., Wobus, Manja, List, Catrin, Wehner, Rebekka, Schönefeldt, Claudia, Brocard, Barbara, Mohr, Brigitte, Rauner, Martina, Schmitz, Marc, Stiehler, Maik, Ehninger, Gerhard, Hofbauer, Lorenz C., Bornhäuser, Martin, Platzbecker, Uwe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ferrata Storti Foundation 2013
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815166/
https://ncbi.nlm.nih.gov/pubmed/23716561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.083972
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg